昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

休市中 05-03 16:09:00

8.940

+0.130

+1.48%

最高9.210	最低8.800	成交量26.66万
今开8.900	昨收8.810	日振幅4.65%
总市值67.04亿	流通市值10.64亿	总股本7.50亿
成交额239.03万	换手率0.22%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":8.94,"timestamp":1714723740034,"preClose":8.81,"halted":0,"volume":266563,"delay":0,"floatShares":118995206,"shares":749888699,"eps":0.5768832,"marketStatus":"休市中","marketStatusCode":7,"change":0.13,"latestTime":"05-03 16:09:00","open":8.9,"high":9.21,"low":8.8,"amount":2390347,"amplitude":0.046538,"askPrice":9,"askSize":6200,"bidPrice":8.93,"bidSize":7600,"shortable":0,"etf":0,"ttmEps":-0.0913750331945345,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"listingDate":1614268800000,"adjPreClose":8.81,"dividendRate":0.019443,"openAndCloseTimeList":[[1714699800000,1714708800000],[1714712400000,1714723200000]],"volumeRatio":0.13945125584856952,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06127/","defaultTab":"news","newsList":[{"id":"2432645632","title":"昭衍新药盘中异动 股价大涨5.05%报8.731港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432645632","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432645632?lang=zh_cn&edition=full","pubTime":"2024-05-02 14:16","pubTimestamp":1714630603,"startTime":"0","endTime":"0","summary":"2024年05月02日下午盘14时16分，昭衍新药股票出现波动，股价急速上涨5.05%。截至发稿，该股报8.731港元/股，成交量59.332万股，换手率0.50%，振幅7.58%。昭衍新药股票所在的生物技术行业中，整体涨幅为1.66%。消息层面，截至14时16分，昭衍新药股票正面舆情新闻比例12.5%。该信息摘要如下：4月29日晚，国内CRO龙头昭衍新药发布2024年一季度业绩报告。但随着支持政策陆续出台，上游创新药企业整体回暖，将有望带动CRO迎来周期拐点。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021416437a57e7c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021416437a57e7c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431676853","title":"智通AH统计|4月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2431676853","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431676853?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:15","pubTimestamp":1714464905,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止4月30日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1073.91%、760.90%、616.97%；招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位，溢价率分别为19.65%、21.39%、21.91%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116187.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431967380","title":"昭衍新药-9.99%跌停，总市值122.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431967380","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431967380?lang=zh_cn&edition=full","pubTime":"2024-04-30 11:21","pubTimestamp":1714447313,"startTime":"0","endTime":"0","summary":"4月30日，昭衍新药盘中-9.99%跌停，截至11:16，报16.39元/股，成交4.98亿元，换手率4.72%，总市值122.91亿元。截至3月31日，昭衍新药股东户数7.42万，人均流通股1.01万股。2024年1月-3月，昭衍新药实现营业收入3.25亿元，同比减少12.07%；归属净利润-2.72亿元，同比减少244.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301121588b647e30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301121588b647e30&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431380633","title":"异动快报：昭衍新药（603127）4月30日11点18分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2431380633","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431380633?lang=zh_cn&edition=full","pubTime":"2024-04-30 11:20","pubTimestamp":1714447233,"startTime":"0","endTime":"0","summary":"证券之星4月30日盘中消息，11点18分昭衍新药触及跌停板。目前价格16.39，下跌9.99%。其所属行业医疗服务目前下跌。领涨股为诺泰生物。该股为创新药，医药，基因编辑概念热股，当日创新药概念上涨0.66%，医药概念上涨0.6%，基因编辑概念上涨0.2%。4月29日的资金流向数据方面，主力资金净流入1056.39万元，占总成交额2.87%，游资资金净流出2985.98万元，占总成交额8.1%，散户资金净流入1929.6万元，占总成交额5.24%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000024351.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431800232","title":"港股异动 | 昭衍新药(06127)跌超11% 实验猴减值影响扩大 公司首季同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2431800232","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431800232?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:48","pubTimestamp":1714441686,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昭衍新药(06127)跌超11%，截至发稿，跌11.12%，报8.79港元，成交额1428.72万港元。消息面上，昭衍新药发布2024年一季报，报告期内公司实现总营收3.25亿元，同比下降12.07%；净亏损2.72亿元，同比由盈转亏。公司在财报中将亏损归因于生物资产市价波动和实验室服务业务亏损。其一，生物资产公允价值变动带来净亏损为2.84亿元。其二，实验室服务业务导致亏损2104.37万元，同比下降130.01%。实验室服务业务净亏损主要源于竞争加剧，毛利率下滑带来的影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116042.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431180789","title":"昭衍新药盘中异动 快速下跌6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431180789","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431180789?lang=zh_cn&edition=full","pubTime":"2024-04-30 09:30","pubTimestamp":1714440612,"startTime":"0","endTime":"0","summary":"2024年04月30日早盘09时30分，昭衍新药股票出现异动，股价快速跳水6.87%。昭衍新药股票所在的生物技术行业中，整体涨幅为0.95%。消息层面，截至09时30分，昭衍新药股票正面舆情新闻比例15.38%。该信息摘要如下：4月29日晚，国内CRO龙头昭衍新药发布2024年一季度业绩报告。但随着支持政策陆续出台，上游创新药企业整体回暖，将有望带动CRO迎来周期拐点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430093013861ea2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430093013861ea2b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431170438","title":"图解昭衍新药一季报：第一季度单季净利润同比减244.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431170438","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431170438?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:12","pubTimestamp":1714414356,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药2024年一季报显示，公司主营收入3.25亿元，同比下降12.07%；归母净利润-2.72亿元，同比下降244.98%；扣非净利润-2.81亿元，同比下降251.92%；负债率17.87%，投资收益697.2万元，财务费用-2801.15万元，毛利率32.84%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000002982.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431723852","title":"昭衍新药(603127.SH)发布一季度业绩，净亏损2.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431723852","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431723852?lang=zh_cn&edition=full","pubTime":"2024-04-29 20:55","pubTimestamp":1714395337,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(603127.SH)披露2024年第一季度报告，报告期公司实现营收3.25亿元，同比下降12.07%;归母净利润亏损2.72亿元;扣非净利润亏损2.81亿元。基本每股收益-0.36元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1115030.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431832346","title":"昭衍新药(06127)一季度归母净亏损2.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431832346","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431832346?lang=zh_cn&edition=full","pubTime":"2024-04-29 19:12","pubTimestamp":1714389128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)发布2024年度第一季度报告，营业收入3.25亿元(人民币，下同)，同比下降12.07%;归属于上市公司股东的净亏损2.72亿元，上年同期利润1.88亿元;基本每股亏损0.36元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1114695.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431296060","title":"昭衍新药盘中异动 早盘股价大涨5.16%报10.181港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431296060","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431296060?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:10","pubTimestamp":1714360241,"startTime":"0","endTime":"0","summary":"2024年04月29日早盘11时10分，昭衍新药股票出现波动，股价大幅拉升5.16%。截至发稿，该股报10.181港元/股，成交量52.2472万股，换手率0.44%，振幅6.20%。资金方面，该股资金流入295.923万港元，流出154.218万港元。昭衍新药股票所在的生物技术行业中，整体涨幅为1.57%。其相关个股中，乐普生物-B、欧康维视生物-B、维亚生物涨幅较大，振幅较大的相关个股有乐普生物-B、欧康维视生物-B、来凯医药-B，振幅分别为12.10%、11.75%、11.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291110417924acee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291110417924acee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431053049","title":"昭衍新药4月26日获北向资金加仓205.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431053049","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431053049?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:30","pubTimestamp":1714354229,"startTime":"0","endTime":"0","summary":"4月26日, 北向资金增持昭衍新药205.06万股。截止当日收盘，沪股通共持有昭衍新药1113.40万股，占流通股1.76%。沪股通增持金额前五个股分别为招商银行、贵州茅台、兴业银行、药明康德、三一重工。昭衍新药近5个交易日上涨3.52%，沪股通累计增持182.23万股；近20个交易日下跌5.34%，沪股通累计增持225.97万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909351987bca56c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042909351987bca56c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430293136","title":"南向资金4月25日净买入昭衍新药20.82万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2430293136","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430293136?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:31","pubTimestamp":1714095092,"startTime":"0","endTime":"0","summary":"4月25日, 南向资金增持昭衍新药20.82万股，连续3日增持。截止当日收盘，港股通共持有昭衍新药3884.50万股，占流通股32.63%。昭衍新药近5个交易日下跌3.14%，港股通累计增持57.33万股；近20个交易日上涨1.20%，港股通累计增持166.15万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260943198b54fb1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404260943198b54fb1d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430412933","title":"昭衍新药4月23日获融资净买入922万元 环比增加24961.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430412933","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430412933?lang=zh_cn&edition=full","pubTime":"2024-04-25 10:00","pubTimestamp":1714010412,"startTime":"0","endTime":"0","summary":"4月23日，昭衍新药获融资净买入922万元，环比上一交易日增加24961.32%。其中，融资买入3156万元，融资偿还2233万元。融券方面，融券卖出24.42万股，当前融券余量为231.51万股。A股市场共有3344股获融资净买入，昭衍新药净买入额排名第176。股市有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251001478b51000f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251001478b51000f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429912787","title":"昭衍新药获融资买入0.32亿元，近三日累计买入0.59亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429912787","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2429912787?lang=zh_cn&edition=full","pubTime":"2024-04-24 08:21","pubTimestamp":1713918104,"startTime":"0","endTime":"0","summary":"4月23日，沪深两融数据显示，昭衍新药获融资买入额0.32亿元，居两市第212位，当日融资偿还额0.22亿元，净买入922.46万元。最近三个交易日，19日-23日，昭衍新药分别获融资买入0.15亿元、0.12亿元、0.32亿元。融券方面，当日融券卖出24.42万股，净卖出19.09万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042408214787a82763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042408214787a82763&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429996911","title":"智通AH统计|4月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2429996911","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429996911?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:15","pubTimestamp":1713773706,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止4月22日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1185.71%、754.10%、608.76%；招商银行、比亚迪股份、潍柴动力分列AH溢价率末三位，溢价率分别为23.62%、24.41%、29.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106450.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429969671","title":"南向资金4月19日净买入昭衍新药40.14万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429969671","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429969671?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:31","pubTimestamp":1713749478,"startTime":"0","endTime":"0","summary":"4月19日, 南向资金增持昭衍新药40.14万股，连续5日增持。截止当日收盘，港股通共持有昭衍新药3867.31万股，占流通股32.49%。港股通增持金额前五个股分别为腾讯控股、中国移动、建设银行、中国银行、中广核电力。昭衍新药近5个交易日下跌1.50%，港股通累计增持112.67万股；近20个交易日下跌7.65%，港股通累计增持245.63万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094317879ed34e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094317879ed34e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428332056","title":"昭衍新药(06127)：无锡金易赋新生物医药创业投资合伙企业(有限合伙)新增有限合伙人香塘合舆","url":"https://stock-news.laohu8.com/highlight/detail?id=2428332056","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428332056?lang=zh_cn&edition=full","pubTime":"2024-04-19 17:10","pubTimestamp":1713517816,"startTime":"0","endTime":"0","summary":"公司近日已与无锡国联产业投资私募基金管理有限公司、北京宏儒和愉投资管理有限公司、无锡市创新投资集团有限公司、江苏原力产业投资有限公司及香塘合舆(北京)科技有限公司签署《合伙协议》。根据签署的《合伙协议》，本次投资基金事项新增有限合伙人香塘合舆(北京)科技有限公司。同时，作为本基金的有限合伙人之一的香塘合舆为公司的关联法人。香塘合舆认缴出资 1 亿元人民币，占有限合伙 10%份额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105406.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428858687","title":"智通AH统计|4月19日","url":"https://stock-news.laohu8.com/highlight/detail?id=2428858687","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428858687?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:15","pubTimestamp":1713514507,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止4月19日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1167.61%、748.78%、631.25%；招商银行、比亚迪股份、紫金矿业分列AH溢价率末三位，溢价率分别为23.72%、25.09%、25.82%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1105299.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428576994","title":"胡涛2024年一季度表现，嘉实远见企业精选两年持有期混合基金季度跌幅5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428576994","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428576994?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:30","pubTimestamp":1713490236,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2024年一季度末，基金经理胡涛旗下共管理7只基金，本季度表现最佳的为嘉实远见企业精选两年持有期混合，季度净值跌5.24%。胡涛在担任嘉实优质企业混合基金经理的任职期间累计任职回报67.66%，平均年化收益率为5.49%。持有期间的估算收益率为95.07%，持有期间东华软件在2014年到2015年的年报归属净利润增幅达9.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041900017336.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428233456","title":"医疗服务行业盘中拉升，昭衍新药涨6.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428233456","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428233456?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:44","pubTimestamp":1713318269,"startTime":"0","endTime":"0","summary":"04月17日，医疗服务行业盘中拉升，截至09点44分，医疗服务行业整体指数上涨2.02%，报4532.820点。从个股上来看，该行业的成分股中，昭衍新药涨6.38%，兰卫医学、成都先导等6只股涨幅超过5%。从资金上来看，截止发稿，医疗服务行业主力净流入为-897.05万，其中爱尔眼科受到资金热捧，主力净流入1568.37万；拉长时间线来看，该板块近20日主力资金净流入-157.16亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709442987e811c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041709442987e811c9&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0764},{"period":"1month","weight":-0.0335},{"period":"3month","weight":-0.0397},{"period":"6month","weight":-0.3959},{"period":"1year","weight":-0.6002},{"period":"ytd","weight":-0.3048}],"compareEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":0.1047},{"period":"3month","weight":0.1894},{"period":"6month","weight":0.046},{"period":"1year","weight":-0.0738},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。非临床研究服务包括药物安全性评价、药代动力学研究以及药理和药效学研究。临床试验及相关服务包括临床合同研究组织服务、一期临床研究协作单位 (CRU)，以及生物分析服务。实验模型业务主要包括啮齿类及非人灵长类动物。该公司在国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.116163},{"month":2,"riseRate":0.666667,"avgChangeRate":-0.004244},{"month":3,"riseRate":0.25,"avgChangeRate":-0.02162},{"month":4,"riseRate":0.25,"avgChangeRate":-0.06496},{"month":5,"riseRate":0.75,"avgChangeRate":0.043251},{"month":6,"riseRate":0.666667,"avgChangeRate":0.066228},{"month":7,"riseRate":1,"avgChangeRate":0.051077},{"month":8,"riseRate":0,"avgChangeRate":-0.202169},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.126744},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.049121},{"month":11,"riseRate":0.333333,"avgChangeRate":0.093591},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.082054}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}